XenoGesis has been shortlisted as a finalist in the prestigious Medilink UK Healthcare Business Awards, held in association with Med-Tech Innovation, on 1st April 2020 at the Hilton Birmingham Metropole.
This comes following XenoGesis’ success at the Medilink East Midlands Business Awards in December where it work the regional award for export achievement.
XenoGesis reported rapid export growth last year and now has clients across six continents. Exports now account for over half of all revenue; an increase that is the direct result of the business’ growth strategy to develop overseas markets.
The UK awards ceremony celebrates the outstanding business achievements, international successes and innovative breakthroughs made across the life sciences and healthcare technology sectors in the past year.
For more information, visit the Medilink UK website.